(2023) conducted a mixed-method investigation combining social media analytics and a remote self-report study in individuals with obesity (BMI 30) who were current alcohol consumers
GLP-1 medications work by increasing insulin secretion, decreasing glucagon secretion, delaying gastric emptying, and reducing appetite, which collectively lead to weight loss and improved metabolic health
Nisha Dahiya +2 more Table of Contents Glucagon-like peptide-1 (GLP-1) medications are gaining popularity for their benefits for type-2-diabetes and weight management 1
Whatever your motivation, you are in expert hands from start to finish
If dairy doesnt work for your system or you dont eat animal products, the next best thing is pea protein
The LEADER trial showed that liraglutide reduced the risk of major cardiovascular events in people with type 2 diabetes.[4] Soon after, SUSTAIN-6 demonstrated similar benefits with semaglutide.[5] Then came REWIND, which suggested that cardiovascular protection could extend even to patients without established cardiovascular disease.[6] The SELECT trial made headlines because it showed cardiovascular benefits in people with overweight or obesity who did not have diabetes, a finding that challenged long-held assumptions about who might benefit from these medicines.[7] Most recently, an international trial called SOUL, which tested an oral form of semaglutide, included 788 Indian patients across 32 centres
